<DOC>
	<DOCNO>NCT00115024</DOCNO>
	<brief_summary>The purpose study determine effect estrogen replacement therapy ( ERT ) progression early atherosclerosis healthy postmenopausal woman without preexist cardiovascular disease ( CVD ) .</brief_summary>
	<brief_title>EPAT : Estrogen Prevention Atherosclerosis Trial</brief_title>
	<detailed_description>The primary goal randomize , control trial determine ERT stabilize , retard , and/or revers progression atherosclerosis postmenopausal woman . We evaluate association lipid non-lipid factor ERT-mediated reduction progression early atherosclerosis . Ultrasonography use measure rate change thickness carotid artery . Blood sample use measure lipid non-lipid mediator ERT . A total 222 healthy postmenopausal woman 46 80 year old without CVD symptom randomize receive either micronized 17B-estradiol ( Estrace ) 1mg/day , match placebo tablet daily . All woman low fat/low cholesterol diet , receive pravastatin LDL cholesterol level exceed 160 mg/dL . Participants undergo ultrasonography baseline every 6 month throughout 2 year randomize treatment . Measurements lipid non-lipid biochemical marker also do baseline every 6 month .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Postmenopausal female ( serum estradiol le 20 pg/ml ) 46 80 year old Fasting LDLC level 130 210 mg/dL Triglyceride level less 400 mg/dL Current nonsmoker Clinical evidence cardiovascular disease HDLC level le 30 mg/dL Fasting blood glucose great 200 mg/dL Previous hormonal replacement therapy ( noncontraceptive ) 10 year duration and/or current use within 1 month Uncontrolled hypertension Untreated thyroid disease Renal insufficiency Clinical evidence congestive heart failure Life threaten disease prognosis le 5 year Alcohol intake great 5 drink per day ( 1 drink = 1 1/2 oz distil spirit , 4 oz wine , 12 oz beer ) substance abuse ( intravenous drug abuse , cocaine use ) History estrogen dependent cancer detect screen disorder precluding use ERT Hot flash great 5 per day interfere daily activity preclude randomization placebo .</criteria>
	<gender>Female</gender>
	<minimum_age>46 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>cardiovascular disease</keyword>
	<keyword>CVD</keyword>
	<keyword>estrogen</keyword>
	<keyword>cholesterol</keyword>
	<keyword>LDL</keyword>
	<keyword>lipid</keyword>
	<keyword>postmenopausal</keyword>
</DOC>